Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Operating Leases (2019 - 2025)

Historic Operating Leases for Collegium Pharmaceutical (COLL) over the last 7 years, with Q3 2025 value amounting to $4.5 million.

  • Collegium Pharmaceutical's Operating Leases fell 2389.25% to $4.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.5 million, marking a year-over-year decrease of 2389.25%. This contributed to the annual value of $5.5 million for FY2024, which is 955.26% down from last year.
  • According to the latest figures from Q3 2025, Collegium Pharmaceutical's Operating Leases is $4.5 million, which was down 2389.25% from $4.9 million recorded in Q2 2025.
  • Collegium Pharmaceutical's 5-year Operating Leases high stood at $8.6 million for Q1 2021, and its period low was $4.5 million during Q3 2025.
  • For the 5-year period, Collegium Pharmaceutical's Operating Leases averaged around $6.7 million, with its median value being $6.6 million (2023).
  • As far as peak fluctuations go, Collegium Pharmaceutical's Operating Leases plummeted by 736.22% in 2024, and later tumbled by 2389.25% in 2025.
  • Quarter analysis of 5 years shows Collegium Pharmaceutical's Operating Leases stood at $8.0 million in 2021, then decreased by 10.55% to $7.1 million in 2022, then fell by 13.89% to $6.1 million in 2023, then fell by 9.55% to $5.5 million in 2024, then dropped by 18.74% to $4.5 million in 2025.
  • Its Operating Leases stands at $4.5 million for Q3 2025, versus $4.9 million for Q2 2025 and $5.2 million for Q1 2025.